• Biotech Investor Lunch

    NanaSteak
    NanaSteak 345 Blackwell St, Durham, NC, United States

    We are excited to host an invite-only Biotech Investor Lunch during Venture Connect. This is a unique opportunity to network with fellow biotech investors over lunch and engage in insightful conversations. Thank you to Seward & Kissel & Dean Dorton for sponsoring this lunch!  

  • Is Your Board Keeping You Up at Night?

    NanaSteak
    NanaSteak 345 Blackwell St, Durham, NC, United States

    At their best, Boards can be a founder's most valuable asset, providing the right level of accountability, invaluable strategic advice, and connections that lead directly to new knowledge, revenue, or talent. But at their worst, Boards can create distraction and overhead, apply unhealthy pressure, or even become an impediment to the company's success. In this […]

  • Collaborative Intelligence in Action, Charting the Path Forward for your Organization

    NanaSteak
    NanaSteak 345 Blackwell St, Durham, NC, United States

    Led by Chloë Domergue, Human Capital Deloitte Principal, this hands-on workshop explores what collaborative intelligence between humans and AI looks like inside a real organization. The next leap in performance will not come from better tools alone. It will come from teams that think differently, challenge assumptions, and work intentionally with intelligent systems. Through guided […]

  • Tech Investor Lunch

    NanaSteak
    NanaSteak 345 Blackwell St, Durham, NC, United States

    We are excited to host an invite-only Tech Investor Lunch during Venture Connect. This is a unique opportunity to network with fellow tech investors over lunch and engage in insightful conversations. Thank you to KPMG for sponsoring this lunch!

  • The Science Leading NC’s Next Biotech Wave

    NanaSteak
    NanaSteak 345 Blackwell St, Durham, NC, United States

    The Triangle's next biotech companies are already taking shape in university labs. This session brings six faculty scientists to the stage to present discoveries at the frontier of venture formation — giving investors an early look at the human health innovations poised to anchor the Triangle's next wave of biotech companies.